2023-11-15T17:51:07-06:00 2022-12-31 PwC US Tax LLP 655 NEW YORK AVE NW SUITE 1100 WASHINGTON DC 20001 990 2022-01-01 530196548 AMERICAN TYPE CULTURE COLLECTION % SCOTT BOLLER AMER 7033652700 10801 UNIVERSITY BLVD MANASSAS VA 201102209 SCOTT BOLLER CFO 7033652754 2023-11-15 true SCOTT BOLLER 999009999 TRAVIS L PATTON P00369623 2024141000 2023-11-14 2 2022 2023-04-26 12:10:37Z RAYMOND H CYPESS 10801 UNIVERSITY BLVD MANASSAS VA 201102209 191538613 false X WWW.ATCC.ORG X 1947 DC TO ACQUIRE, AUTHENTICATE, PRESERVE, DEVELOP & DISTRIBUTE BIOLOGICAL MATERIALS, INFORMATION, TECHNOLOGY AND STANDARDS FOR THE ADVANCEMENT AND APPLICATION OF SCIENTIFIC KNOWLEDGE. 9 8 718 0 1944626 0 1000000 6000000 61794143 72154119 17923 51606 95047357 96394263 157859423 174599988 31000000 26000000 0 0 58180207 70642131 0 0 0 56220605 64204737 145400812 160846868 12458611 13753120 193352265 217778463 54414413 63501468 138937852 154276995 X THE AMERICAN TYPE CULTURE COLLECTION (ATCC) IS A GLOBAL NON PROFIT BIOSCIENCE ORGANIZATION WHOSE MISSION IS TO ACQUIRE, AUTHENTICATE, PRESERVE, DEVELOP, AND DISTRIBUTE BIOLOGICAL MATERIALS, INFORMATION, TECHNOLOGY, INTELLECTUAL PROPERTY, AND STANDARDS FOR THE ADVANCEMENT, VALIDATION, AND APPLICATION OF SCIENTIFIC KNOWLEDGE. ATCC PROVIDES THESE SERVICES TO SCIENTISTS IN GOVERNMENT, INDUSTRY, EDUCATION, HEALTHCARE, AND RESEARCH LABORATORIES AROUND THE WORLD. false false 85260131 0 65980765 COLLECTIONS, RESEARCH AND INFORMATICS SERVICES: A 97 YEAR OLD ONGOING PROGRAM FOR THE ISOLATION, COLLECTION, ACQUISITION AND PROVISION OF AUTHENTIC CULTURES OF LIVING MICROORGANISMS, HUMAN, ANIMAL AND PLANT CELLS, DERIVATIVES INCLUDING GENETIC MATERIALS AND RELATED BIOPRODUCTS IN SUPPORT OF SCIENCE. THE COLLECTION'S SIZE WAS WELL OVER 100,000 STRAINS AND DNA AND RDNA MATERIALS, AND OVER 300,000 BIOLOGICAL ITEMS WERE DISTRIBUTED TO THOUSANDS OF SCIENTISTS WORLDWIDE. IN ADDITION TO THE MATERIALS, ATCC MAINTAINS EXTENSIVE INFORMATION ABOUT THE SPECIMENS, AND RELATED PRESERVATION AND LAB TECHNIQUES THERETO, IN THE COLLECTIONS. THIS INFORMATION IS MADE AVAILABLE TO THE SCIENTIFIC COMMUNITY THROUGH PUBLICATIONS AND THE EXTENSIVE ATCC INTERNET WEB SITE. 26000000 26000000 0 GRANT TO SUPPORT RELATED ENTITY WHOSE MISSION IS ALIGNED WITH ATCC (ATCC GLOBAL). 774310 0 6173354 PROFESSIONAL SERVICES: THIS PROGRAM ENCOMPASSES SEVERAL ACTIVITIES RELATED TO THE SUPPORT OF THE ATCC COLLECTIONS, PROVIDING SPECIAL SUPPORT SERVICES TO THE SCIENTIFIC COMMUNITY (1) APPLIED SCIENCES: PROVIDES EXPERT TECHNICAL SUPPORT TO THE SCIENTIFIC COMMUNITY TO PROPERLY IDENTIFY, HANDLE OR OTHERWISE UTILIZE BIOLOGICAL MATERIALS. THESE ACTIVITIES INCLUDE LABORATORY, PROFESSIONAL CONSULTATION, OR TECHNICAL MANAGEMENT SERVICES. (2) PATENT DEPOSIT SERVICES: ATCC PROVIDES STORAGE FACILITIES FOR SAFEGUARDING CULTURES DEPOSITED FOR PATENT PURPOSES. UNDER THE USPTO RULES THESE DEPOSITS MUST BE MADE AVAILABLE, ON ISSUANCE OF THE PATENT, TO FURTHER ENHANCE SCIENTIFIC RESEARCH. ATCC PROVIDES SAFEKEEPING OF THE CULTURES AND DISTRIBUTION TO THE RESEARCH SCIENTISTS. 112034441 true true false false false false false false false true true false false true true true false true false true false false false false false false false true false true false false false false false false false false false false false false false true true true false false true 103 0 718 true true true false false false false false false false false false true false X 9 8 true false false false true true true true true false false true true true true true true true true false CA MD VA X SCOTT BOLLER 7033652754 10801 UNIVERSITY BLVD MANASSAS VA 201102209 RAYMOND H CYPESS CEO, CHAIRMAN 37.5 1.8 X X 2124433 0 64298 JOSEPH LEONELLI VP, ATCC FEDERAL SOLUTION/AMS 37.5 0.0 X 521420 0 40200 RUTH CHENG CHIEF STRATEGY & INNOV OFFICER 37.5 0.0 X 418460 0 53396 THERESE SELLARS ASST SEC./VP HR/CPO 37.5 1.8 X 385190 0 52173 GREGORY FORTON ASST TREAS/CFO/VP (AS OF 3/22) 37.5 1.8 X 387298 0 49665 PATRICK LAVERTY VP, QA, SFTY & PROD COMPL 37.5 0.0 X 380906 0 52173 DANIEL KELLY CIO/CTO 37.5 0.0 X 397096 0 35820 GREGORY BALLISH CHIEF COMMERCIAL OFFICER 37.5 0.0 X 372950 0 47160 JAMES J KRAMER VP, OPERATIONS (UNTIL 3/22) 37.5 0.0 X 353480 0 12291 ROBERT GOWIN CHIEF STRATEGY REALIZATION OFC 37.5 0.0 X 309515 0 36414 LINDA JOHNSON SR DIR LICENSING & IP 37.5 0.0 X 280425 0 32275 PETER LANGLAIS DIR. GLOBAL SALES & CUST. SOL. 37.5 0.0 X 270041 0 33614 REBECCA BRADFORD SR DIR, GOVERNMENT PROGRAMS 37.5 0.0 X 274594 0 26581 JONATHAN JACOBS SR. DIR. BIOINFO & PRIN. SCI. 37.5 0.0 X 259236 0 33583 NILAY CHAKRABORTY PRINCIPAL SCIENTIST, BIO 37.5 0.0 X 247642 0 29451 KIM TESTA SR DIR CORP COMMUNICATIONS 37.5 0.0 X 231058 0 34191 JOHN SWEENEY ASST TREAS/CFO/VP (UNTIL 3/22) 37.5 1.8 X 105462 0 14744 STEVE KAMINSKY BOARD MEMBER 0.6 1.2 X 32100 0 0 LYDIA VILLA-KOMAROFF BOARD MEMBER/SEC. (UNTIL 9/22) 0.6 1.8 X X 27600 0 0 JOSHUA LABAER BOARD MEMBER 0.6 1.2 X 26950 0 0 PATRICK BOURKE BRD MEMBER/TREAS. (UNTIL 9/22) 0.6 1.2 X X 26450 0 0 HEATHER KIESSLING BRD MEMBER/TREAS. (AS OF 9/22) 0.6 1.8 X X 22750 0 0 MELISSA REWOLINSKI BOARD MEMBER/SEC. (AS OF 9/22) 0.6 1.8 X X 21500 0 0 LESLIE LENERT BOARD MEMBER 0.6 1.2 X 15500 0 0 STEVE CURTS BOARD MEMBER 0.6 1.2 X 15000 0 0 7507056 0 648029 156 false true false AIRO DIGITAL LABS LLC 122 PERIWINKLE LANE BOLINGBROOK IL 60490 IT CONSULTING 6419738 DPR CONSTRUCTION 11109 SUNSET HILLS RD RESTON VA 20190 CONSTRUCTION 5531331 LIFELINE CELL TECHNOLOGY 8415 PROGRESS DRIVE SUITE S FREDERICK MD 21701 BIOPRODUCTS SERVICES 3660665 QIAGEN SCIENCES INC 19300 GERMANTOWN RD GERMANTOWN MD 21230 REAGENTS & SUPPLIES 2539303 EWINGCOLE INC 810 LIGHT ST BALTIMORE MD 21230 ARCHITECURAL SVCS 1995285 43 6000000 6000000 FREIGHT & HANDLING 541700 6173354 6173354 APPLIED SERVICES 541900 3302290 3302290 PATENT DEPOSITS 541900 1366648 1366648 FEES AND CONTRACTS FROM GOVT AGENCIES 541700 61311827 61311827 72154119 51606 51606 0 38303382 38303382 504868 680540 0 -175672 -175672 -175672 0 0 0 0 0 0 0 72404340 16258085 56146255 56146255 MANAGEMENT FEES 561000 2120298 2120298 2120298 174599988 72154119 1944626 94501243 26000000 26000000 0 0 0 6667643 3313152 3354491 0 44536547 22130210 22406337 3245748 1612812 1632936 12275349 6099621 6175728 3916844 1946280 1970564 0 759422 133293 626129 278280 278280 0 0 0 20654477 6906263 13748214 1316487 16805 1299682 18520436 15923933 2596503 5210164 13228 5196936 294488 294488 7782053 7748591 33462 308289 66658 241631 0 116961 43541 73420 -2154160 -2154160 0 7874461 7874461 632157 229439 402718 GOV'T SUBCONTRACT LAB SVCS 14180641 14180641 EQUIP RENTAL & MAINTENANCE 158936 158796 140 RECRUITING 759880 60900 698980 TRAINING 286506 95670 190836 -12774741 -2814341 -9960400 160846868 112034441 48812427 0 0 0 10370619 19761523 0 0 38966379 35956898 0 0 0 0 0 0 13250715 13664150 1518320 2430615 172413602 93036605 77628487 79376997 759069 716359 0 0 0 0 0 0 50858676 65871921 193352265 217778463 14924741 16058429 0 0 14582851 13882295 0 0 0 0 0 0 0 0 21250000 23834927 3656821 9725817 54414413 63501468 X 138257513 153596656 680339 680339 138937852 154276995 193352265 217778463 X 13753120 2279295 -693272 X false true X true true true X 0 0 2000000 1000000 6000000 9000000 91275125 105820158 162876891 129455843 144558459 633986476 0 0 0 91275125 105820158 164876891 130455843 150558459 642986476 0 35753472 47586910 99874778 57462080 67046269 307723509 35753472 47586910 99874778 57462080 67046269 307723509 335262967 14471046 18074635 26609258 36666180 38354988 134176107 361209 373558 0 0 0 734767 14832255 18448193 26609258 36666180 38354988 134910874 0 0 106107380 124268351 191486149 167122023 188913447 777897350 0.43099 0.44017 0.17343 0.15823 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 680339 0 0 680339 680339 22594 22594 680339 1937093 30482 1287236 680339 3193846 106409 1363162 1937093 4998244 9054 1813452 3193846 1.00000 false false 2914117 2914117 55185421 13168972 42016449 30073576 21764709 8308867 84240488 58102924 26137564 79376997 DUE FROM AFFILIATES 33042661 457 ASSETS HELD IN TRUST 912816 CONTRACT ASSETS, NET 23975338 RIGHT OF USE ASSET 5608893 INTEREST RATE SWAP ASSET 2332213 65871921 0 POSTRETIREMENT LIABILITY 912816 BUDAPEST TREATY RESERVE 5000 DUE TO AFFILIATES 2733940 INCOME TAXES PAYABLE 38468 LEASE LIABILITY 6035593 9725817 X PART V, LINE 4: INTENDED USE OF THE ORGANIZATION'S ENDOWMENT FUNDS: ATCC'S PERMANENT ENDOWMENT IS RESTRICTED IN SUPPORT OF THE GENERAL OPERATIONS OF ATCC. THE BOARD OF DIRECTORS APPROVES AN OPERATING BUDGET ANNUALLY AND ALL INVESTMENT EARNINGS ON THE PERMANENT ENDOWMENT ARE AVAILABLE TO FUND THE OPERATIONS OF ATCC. PART X, LINE 2: AS PER CONSOLIDATED FINANCIAL STATEMENTS, OF WHICH ATCC IS REPORTED AS A SUBSIDIARY: ATCC GLOBAL, ATCC, AND THE BIONEXUS FOUNDATION ARE EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE (IRC) AND APPLICABLE INCOME TAX REGULATIONS OF THE COMMONWEALTH OF VIRGINIA, EXCEPT FOR INCOME FROM ACTIVITIES NOT RELATED TO THEIR TAX-EXEMPT PURPOSE. ATCC GLOBAL, ATCC, AND THE BIONEXUS FOUNDATION RECOGNIZE OR DERECOGNIZE TAX POSITIONS ON A "MORE LIKELY THAN NOT" THRESHOLD. THIS APPLIES TO POSITIONS TAKEN OR EXPECTED TO BE TAKEN IN A TAX RETURN. ATCC CELL SYSTEMS AND BIO ESSENTIALS LTD ACCRUE INCOME TAXES CURRENTLY PAYABLE AND ALSO RECOGNIZES DEFERRED TAX ASSETS AND LIABILITIES FOR THE ESTIMATED FUTURE TAX CONSEQUENCES OF TEMPORARY DIFFERENCES. TEMPORARY DIFFERENCES ARE THE RESULT OF DIFFERENCES BETWEEN THE TAX BASIS OF ASSETS AND LIABILITIES AND THEIR FINANCIAL STATEMENT AMOUNTS. DEFERRED TAX ASSETS AND LIABILITIES ARE MEASURED BY APPLYING ENACTED STATUTORY RATES APPLICABLE TO THE FUTURE YEARS IN WHICH DEFERRED TAX ASSETS OR LIABILITIES ARE EXPECTED TO BE SETTLED OR REALIZED. VALUATION ALLOWANCES ARE ESTABLISHED, WHEN NECESSARY, TO REDUCE DEFERRED TAX ASSETS TO THE AMOUNTS EXPECTED TO BE REALIZED. ATCC GLOBAL, ATCC, ACS, BIO ESSENTIALS LTD AND THE BIONEXUS FOUNDATION RECOGNIZE TAX LIABILITIES FOR UNCERTAIN TAX POSITIONS WHEN IT IS MORE LIKELY THAN NOT THAT A TAX POSITION WILL NOT BE SUSTAINED UPON EXAMINATION AND SETTLEMENT WITH VARIOUS TAXING AUTHORITIES. LIABILITIES FOR UNCERTAIN TAX POSITIONS ARE MEASURED BASED UPON THE LARGEST AMOUNT OF BENEFIT THAT IS GREATER THAN 50% LIKELY OF BEING REALIZED UPON SETTLEMENT. THE GUIDANCE ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES ALSO ADDRESSES DE-RECOGNITION, CLASSIFICATION, AND INTEREST AND PENALTIES ON INCOME TAXES. WITH FEW EXCEPTIONS, ATCC GLOBAL, ATCC, ACS AND THE BIONEXUS FOUNDATION ARE NO LONGER SUBJECT TO INCOME TAX EXAMINATIONS BY THE U.S. FEDERAL, STATE OR LOCAL TAX AUTHORITIES FOR YEARS ENDED DECEMBER 31, 2018 AND PRIOR. BIO ESSENTIALS LTD IS SUBJECT TO TAXATION IN THE UNITED KINGDOM AS A PRIVATE LIMITED CORPORATION. MANAGEMENT HAS EVALUATED ATCC GLOBAL, ATCC, BIO ESSENTIALS LTD AND THE BIONEXUS FOUNDATION'S TAX POSITIONS AND HAS CONCLUDED THAT THESE ENTITIES HAVE TAKEN NO UNCERTAIN TAX POSITIONS THAT REQUIRE ADJUSTMENT TO THE CONSOLIDATED FINANCIAL STATEMENTS TO COMPLY WITH THE PROVISIONS OF THIS GUIDANCE. true ATCC GLOBAL 10801 UNIVERSITY BLVD MANASSAS VA 20110 753159126 501(C)(3) 26000000 GENERAL SUPPORT 1 0 PART I, LINE 2: ATCC'S GRANTS WERE MADE TO ATCC GLOBAL, A RELATED ORGANIZATION WHOSE MISSION IS ALIGNED WITH ATCC. ATCC CLOSELY MONITORS THE FINANCIAL PERFORMANCE OF THE ORGANIZATION. X X X true true X X X X X true false false false false false false false false RAYMOND H CYPESS CEO, CHAIRMAN 1464785 0 500000 0 159648 0 43700 0 20598 0 2188731 0 0 0 THERESE SELLARS ASST SEC./VP HR/CPO 294719 0 88200 0 2271 0 23200 0 28973 0 437363 0 0 0 JAMES J KRAMER VP, OPERATIONS (UNTIL 3/22) 57772 0 87415 0 208293 0 7368 0 4923 0 365771 0 0 0 JOSEPH LEONELLI VP, ATCC FEDERAL SOLUTION/AMS 391590 0 114000 0 15830 0 23200 0 17000 0 561620 0 0 0 DANIEL KELLY CIO/CTO 304161 0 90215 0 2720 0 23940 0 11880 0 432916 0 0 0 RUTH CHENG CHIEF STRATEGY & INNOV OFFICER 323766 0 90000 0 4694 0 23200 0 30196 0 471856 0 0 0 GREGORY FORTON ASST TREAS/CFO/VP (AS OF 3/22) 317395 0 65000 0 4903 0 23200 0 26465 0 436963 0 0 0 KIM TESTA SR DIR CORP COMMUNICATIONS 176288 0 52790 0 1980 0 14711 0 19480 0 265249 0 0 0 LINDA JOHNSON SR DIR LICENSING & IP 228930 0 50205 0 1290 0 18744 0 13531 0 312700 0 0 0 REBECCA BRADFORD SR DIR, GOVERNMENT PROGRAMS 229683 0 44461 0 450 0 18850 0 7731 0 301175 0 0 0 PATRICK LAVERTY VP, QA, SFTY & PROD COMPL 289989 0 87500 0 3417 0 23200 0 28973 0 433079 0 0 0 NILAY CHAKRABORTY PRINCIPAL SCIENTIST, BIO 214989 0 30000 0 2653 0 17974 0 11477 0 277093 0 0 0 PETER LANGLAIS DIR. GLOBAL SALES & CUST. SOL. 148928 0 63412 0 57701 0 13213 0 20401 0 303655 0 0 0 JONATHAN JACOBS SR. DIR. BIOINFO & PRIN. SCI. 228501 0 30045 0 690 0 19281 0 14302 0 292819 0 0 0 ROBERT GOWIN CHIEF STRATEGY REALIZATION OFC 265535 0 42000 0 1980 0 21700 0 14714 0 345929 0 0 0 GREGORY BALLISH CHIEF COMMERCIAL OFFICER 334165 0 33750 0 5035 0 26255 0 20905 0 420110 0 0 0 PART I, LINE 1A: TAX INDEMNIFICATION/GROSS UP - THE COMPANY GROSSES UP REIMBURSEMENTS FOR RETIREMENT CONTRIBUTIONS IN EXCESS OF SECTION 403(A) AND 457(B) CONTRIBUTION LIMITS THAT ARE INCLUDED IN EMPLOYEES' TAXABLE WAGES. IN 2022, THIS BENEFIT WAS PROVIDED TO DR. RAYMOND H. CYPESS, THERESE SELLARS, RUTH CHENG, GREGORY FORTON, AND JOSEPH LEONELLI. HEALTH CLUB DUES/FEES - THE COMPANY REIMBURSES A NOMINAL AMOUNT FOR MONTHLY HEALTH CLUB REIMBURSEMENT AS PART OF THE ATCC HEALTH PROGRAM. HOUSING ALLOWANCE OR RESIDENCE FOR PERSONAL USE - AMERICAN TYPE CULTURE COLLECTION PROVIDES HOUSING RELATED ALLOWANCE TO SOME OF ITS EMPLOYEES UPON HIRE, TO FACILITATE THE EMPLOYEE'S RELOCATION. IN 2022, THIS BENEFIT WAS PROVIDED TO PATRICK LAVERTY AND NILAY CHAKRABORTY, OF WHICH THE TOTAL AMOUNT WAS GROSSED UP AND REPORTED AS TAXABLE COMPENSATION ON THEIR FORMS W-2. PART I, LINE 4A: THE INDIVIDUALS DESCRIBED BELOW RECEIVED A SEVERANCE PAYMENT. THE AMOUNT OF THE SEVERANCE PAYMENT IS INCLUDED IN SCHEDULE J, PART II, COLUMN (B)(III): JAMES KRAMER: $175,000 PETER LANGLAIS: $ 45,946 PART VI, LINE 2: RAYMOND CYPESS, JOSHUA LABAER, GREG FORTON, THERESE SELLARS, STEVE CURTS, HEATHER KIESSLING, LYDIA VILLA-KOMAROFF, PATRICK BOURKE, AND JOHN SWEENEY, DIRECTORS AND/OR OFFICERS OF AMERICAN TYPE CULTURE COLLECTION, HAD A BUSINESS RELATIONSHIP DURING THE TAX YEAR. THEY ALL SERVED AS DIRECTORS AND/OR OFFICERS OF ATCC CELL SYSTEMS, INC., A RELATED PARTY DISCLOSED ON SCHEDULE R. RAYMOND CYPESS AND THERESE SELLARS ALSO SERVED AS DIRECTORS OF BIO ESSENTIALS LTD., A RELATED PARTY AS DISCUSSED ON SCHEDULE R. PART VI, LINES 6, 7A, & 7B: AMERICAN TYPE CULTURE COLLECTION ("ATCC") IS A CORPORATION ESTABLISHED UNDER THE DISTRICT OF COLUMBIA NON-PROFIT CORPORATION ACT. IT HAS ONE CORPORATE MEMBER, ATCC GLOBAL, WHICH IS TAX EXEMPT UNDER 501(C)(3) AND IS A TYPE II SUPPORTING ORGANIZATION UNDER 509(A)(3). ATCC GLOBAL HAS THE RIGHT TO ELECT ATCC'S BOARD OF DIRECTORS AND TO VOTE IN ANY CORPORATE PROCEEDING WHICH IS SUBMITTED TO A VOTE OF THE CORPORATE MEMBERSHIP. ATCC'S BOARD OF DIRECTORS HAS THE AUTHORITY TO MANAGE THE BUSINESS AND DO ALL SUCH LAWFUL ACTS AND THINGS AS ARE NOT PROHIBITED BY STATUTE OR BY THE ARTICLES OF INCORPORATION OR ATCC'S BYLAWS. ANY MODIFICATIONS TO THE ARTICLES OF INCORPORATION OR BYLAWS REQUIRE THE APPROVAL OF ATCC GLOBAL. PART VI, LINE 11B: THE FORM 990 IS PREPARED BY PWC US TAX LLP ("PWC"), BASED ON THE INFORMATION PROVIDED BY THE ORGANIZATION'S STAFF. PRIOR TO FILING WITH THE IRS, THE FORM 990 IS MADE AVAILABLE TO THE BOARD, PWC SIGNS AS PREPARER AND THE CHIEF FINANCIAL OFFICER SIGNS ON BEHALF OF THE ORGANIZATION. PART VI, LINE 12C: ATCC HAS A CONFLICT OF INTEREST POLICY THAT REQUIRES OFFICERS AND DIRECTORS TO DISCLOSE ANNUALLY, INTERESTS THAT COULD GIVE RISE TO CONFLICTS. THIS POLICY IS CONSISTENTLY MONITORED AND ENFORCED. BOARD MEMBERS WHO HAVE A CONFLICT OF INTEREST DO NOT VOTE ON ANY MATTER RELATED TO THE ISSUE FOR WHICH THEY HAVE A POTENTIAL CONFLICT. CONFLICT OF INTEREST FORMS ARE DISTRIBUTED TO, AND SIGNED BY, THE MEMBERS OF THE BOARD, AND THEN RETURNED TO OUTSIDE COUNSEL FOR REVIEW. DISCLOSED CONFLICTS, IF ANY, ARE ASSESSED BY OUTSIDE COUNSEL, AND OUTSIDE COUNSEL ASSISTS WITH ANY NECESSARY FOLLOW UP ACTIVITIES. PART VI, LINES 15A & 15B: THE EXECUTIVE COMMITTEE OF THE ATCC GLOBAL BOARD OF DIRECTORS REVIEWS RECOMMENDATIONS MADE BY THE CEO OF ATCC, AND GIVES FINAL APPROVAL FOR THE OVERALL COMPENSATION PROGRAMS FOR ATCC. THESE PROGRAMS MAY INCLUDE SALARY STRUCTURES, MERIT INCREASES, BONUSES AND BENEFITS, AS WELL AS MARKET AND RANGE ADJUSTMENTS. A THIRD-PARTY ANALYSIS OF TOTAL EXECUTIVE COMPENSATION WAS COMPLETED IN DECEMBER 2022. THE EXECUTIVE COMMITTEE REVIEWS AND APPROVES COMPENSATION FOR THE CEO AND EXECUTIVES USING DATA FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS WITHIN SIMILAR INDUSTRIES. DOCUMENTATION OF SUCH DISCUSSIONS AND DECISIONS, AS WELL AS RELATED APPROVALS ARE PROVIDED BY THE VP, HUMAN RESOURCES/CHIEF PEOPLE OFFICER FOR RECORDKEEPING. PART VI, LINE 19: THE ORGANIZATION DOES NOT MAKE ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, OR FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC. PART XI, LINE 9: PROVISION FOR TAXES ($693,272) ------------ ($693,272) FORM 990 PART IX LINE 11G DESCRIPTION:CONSULTING & CONTRACT SVC TOTAL FEES:20654477 ATCC GLOBAL 10801 UNIVERSITY BOULEVARD MANASSAS VA 20110 753159126 SUPPORT ATCC DC 501(c)(3) 12B-TYPE II NA false BIONEXUS FOUNDATION 10801 UNIVERSITY BOULEVARD MANASSAS VA 20110 201512696 SUPPORT ATCC DC 501(c)(3) 12B-TYPE II ATCC GLOBAL false ATCC CELL SYSTEMS INC 10801 UNIVERSITY BOULEVARD MANASSAS VA 201102209 541805129 LAB SERVICES VA ATCC GLOBAL C CORP 0 0 true BIO ESSENTIALS LTD GROUND FLOOR 123 PALL MALL LONDON UK SW1Y 5EA ADMIN UK ATCC GLOBAL C CORP 12472 21951 true true true true true true false false false false true false false false true true false true true false ATCC CELL SYSTEMS INC A(I) 2688348 COST ATCC CELL SYSTEMS INC D 33173471 END BLNC ATCC CELL SYSTEMS INC J 237044 COST ATCC GLOBAL B 26000000 FMV BIONEXUS FOUNDATION C 6000000 FMV